284. Diamond-Blackfan anemia Clinical trials / Disease details
Clinical trials : 37 / Drugs : 110 - (DrugBank : 34) / Drug target genes : 23 - Drug target pathways : 124
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01034592 (ClinicalTrials.gov) | November 2009 | 15/12/2009 | Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia | A Pilot Study of Lenalidomide in Adult Diamond-Blackfan Anemia Patients With Red Blood Cell Transfusion-Dependent Anemia | Anemia;Leukemia;Acute Myeloid Leukemia (AML);Myelodysplastic Syndromes (MDS) | Drug: Lenalidomide | Jason Robert Gotlib | Celgene Corporation | Terminated | 18 Years | N/A | All | 2 | Phase 1 | United States |